
 
													 
									 
															 
															Year
 
															DEALS // DEV.
 
															Country
 
															 
															Therapeutic Area
 
															Study Phase
 
															Deal Type
 
															Product Type
 
															Dosage Form
 
															Lead Product
 
															Target

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Etvax Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Göteborg University | Aurevia | Sahlgrenska University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
A Phase 2 Bridging Study to Assess the New Formulation of ETVAX
Details : Etvax Vaccine is a Vaccine drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Vaccine-Preventable Diseases.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
January 05, 2022
Lead Product(s) : Etvax Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Göteborg University | Aurevia | Sahlgrenska University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Tetravalent Etec Vaccine
Therapeutic Area : Gastroenterology
Study Phase : Phase II
Sponsor : Göteborg University | United Medix Laboratories Ltd. | Medfiles Ltd | University of Helsinki | University of Virginia
Deal Size : Inapplicable
Deal Type : Inapplicable
Prevention of Diarrheal Disease Due to Infection With Enterotoxigenic E. Coli (ETEC)
Details : Tetravalent Etec Vaccine is a Vaccine drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Diarrhea.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
November 02, 2018
Lead Product(s) : Tetravalent Etec Vaccine
Therapeutic Area : Gastroenterology
Highest Development Status : Phase II
Sponsor : Göteborg University | United Medix Laboratories Ltd. | Medfiles Ltd | University of Helsinki | University of Virginia
Deal Size : Inapplicable
Deal Type : Inapplicable

 Reset All
Reset All